539 related articles for article (PubMed ID: 16208597)
21. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
23. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.
Trombetta D; Imbesi S; Vita G; Isola S; Minciullo PL; Saija A; Gangemi S
Arzneimittelforschung; 2009; 59(8):410-4. PubMed ID: 19813464
[TBL] [Abstract][Full Text] [Related]
24. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions.
Quiralte J; Blanco C; Delgado J; Ortega N; Alcntára M; Castillo R; Anguita JL; Sáenz de San Pedro B; Carrillo T
J Investig Allergol Clin Immunol; 2007; 17(3):182-8. PubMed ID: 17583106
[TBL] [Abstract][Full Text] [Related]
25. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
Zembowicz A; Mastalerz L; Setkowicz M; Radziszewski W; Szczeklik A
Arch Dermatol; 2003 Dec; 139(12):1577-82. PubMed ID: 14676074
[TBL] [Abstract][Full Text] [Related]
26. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and other non-steroidal anti-inflammatory drugs.
Liccardi G; Cazzola M; De Giglio C; Manfredi D; Piscitelli E; D'Amato M; D'Amato G
J Investig Allergol Clin Immunol; 2005; 15(4):249-53. PubMed ID: 16433205
[TBL] [Abstract][Full Text] [Related]
27. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies.
Quiralte J; Blanco C; Castillo R; Ortega N; Carrillo T
Ann Allergy Asthma Immunol; 1997 Mar; 78(3):293-6. PubMed ID: 9087155
[TBL] [Abstract][Full Text] [Related]
28. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization.
Sun SX; Lee KY; Bertram CT; Goldstein JL
Curr Med Res Opin; 2007 Aug; 23(8):1859-66. PubMed ID: 17605893
[TBL] [Abstract][Full Text] [Related]
29. Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs.
Viola M; Quaratino D; Gaeta F; Caringi M; Valluzzi R; Caruso C; Volpetti S; Romano A
Int Arch Allergy Immunol; 2005 Jun; 137(2):145-50. PubMed ID: 15897671
[TBL] [Abstract][Full Text] [Related]
30. Urticaria and angioedema from cyclooxygenase-2 inhibitors.
Kelkar PS; Butterfield JH; Teaford HG
J Rheumatol; 2001 Nov; 28(11):2553-4. PubMed ID: 11708434
[TBL] [Abstract][Full Text] [Related]
31. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
[TBL] [Abstract][Full Text] [Related]
32. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
[TBL] [Abstract][Full Text] [Related]
33. [Allergic and pseudoallergic reactions to analgesics, antipyretics and non-steroidal anti-inflammatory drugs].
Ponvert C; Scheinmann P
Arch Pediatr; 2007 May; 14(5):507-12. PubMed ID: 17442550
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous reactions to non-steroidal anti-inflammatory drugs.
Kasemsarn P; Kulthanan K; Tuchinda P; Dhana N; Jongjarearnprasert K
J Drugs Dermatol; 2011 Oct; 10(10):1160-7. PubMed ID: 21968666
[TBL] [Abstract][Full Text] [Related]
35. Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs.
Asero R; Tedeschi A; Lorini M
Ann Allergy Asthma Immunol; 2002 May; 88(5):468-72. PubMed ID: 12027067
[TBL] [Abstract][Full Text] [Related]
36. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
Göksel O; Aydin O; Misirligil Z; Demirel YS; Bavbek S
J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786
[TBL] [Abstract][Full Text] [Related]
37. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
[TBL] [Abstract][Full Text] [Related]
38. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance.
Blanca-Lopez N; J Torres M; Doña I; Campo P; Rondón C; Seoane Reula ME; Salas M; Canto G; Blanca M
Clin Exp Allergy; 2013 Jan; 43(1):85-91. PubMed ID: 23278883
[TBL] [Abstract][Full Text] [Related]
39. Tolerability of nimesulide in aspirin-sensitive patients.
Andri L; Senna G; Betteli C; Givanni S; Scaricabarozzi I; Mezzelani P; Andri G
Ann Allergy; 1994 Jan; 72(1):29-32. PubMed ID: 8291746
[TBL] [Abstract][Full Text] [Related]
40. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome.
Gamboa P; Sanz ML; Caballero MR; Urrutia I; Antépara I; Esparza R; de Weck AL
Clin Exp Allergy; 2004 Sep; 34(9):1448-57. PubMed ID: 15347380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
